NCT03375320 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 64
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 298
- units
- Participants
- groups
- description
- Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study.\> \> Cabozantinib S-malate: Given PO\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG000
- title
- Arm Ia (Cabozantinib S-malate, Extra-pancreatic NET Cohort [epNET])
- description
- Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Placebo Administration: Given PO\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG001
- title
- Arm IIa (Placebo, Extra-pancreatic NET Cohort [epNET])
- description
- Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study.\> \> Cabozantinib S-malate: Given PO\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG002
- title
- Arm Ib (Cabozantinib S-malate, Pancreatic NET Cohort [pNET])
- description
- Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Placebo Administration: Given PO\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG003
- title
- Arm IIb (Placebo, Pancreatic NET Cohort [pNET])
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 28
- upper Limit
- 86
- value
- 66
- group Id
- BG001
- lower Limit
- 30
- upper Limit
- 82
- value
- 66
- group Id
- BG002
- lower Limit
- 29
- upper Limit
- 79
- value
- 59.5
- group Id
- BG003
- lower Limit
- 39
- upper Limit
- 79
- value
- 64
- group Id
- BG004
- lower Limit
- 28
- upper Limit
- 86
- value
- 66
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 145
- title
- Female
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 37
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 153
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 21
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 125
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 61
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 268
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 9
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 8
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 22
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 115
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 54
- group Id
- BG003
- value
- 25
- group Id
- BG004
- value
- 249
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 16
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 64
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 298
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 64
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 298
- units
- Participants
- groups
- description
- Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study.\> \> Cabozantinib S-malate: Given PO\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG000
- title
- Arm Ia (Cabozantinib S-malate, Extra-pancreatic NET Cohort [epNET])
- description
- Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Placebo Administration: Given PO\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG001
- title
- Arm IIa (Placebo, Extra-pancreatic NET Cohort [epNET])
- description
- Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study.\> \> Cabozantinib S-malate: Given PO\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG002
- title
- Arm Ib (Cabozantinib S-malate, Pancreatic NET Cohort [pNET])
- description
- Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.\> \> Computed Tomography: Undergo CT\> \> Magnetic Resonance Imaging: Undergo MRI\> \> Placebo Administration: Given PO\> \> Quality-of-Life Assessment: Ancillary studies\> \> X-Ray Imaging: Undergo x-ray
- id
- BG003
- title
- Arm IIb (Placebo, Pancreatic NET Cohort [pNET])
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 28
- upper Limit
- 86
- value
- 66
- group Id
- BG001
- lower Limit
- 30
- upper Limit
- 82
- value
- 66
- group Id
- BG002
- lower Limit
- 29
- upper Limit
- 79
- value
- 59.5
- group Id
- BG003
- lower Limit
- 39
- upper Limit
- 79
- value
- 64
- group Id
- BG004
- lower Limit
- 28
- upper Limit
- 86
- value
- 66
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 145
- title
- Female
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 37
- group Id
- BG003
- value
- 18
- group Id
- BG004
- value
- 153
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 21
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 125
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 61
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 268
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 9
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 8
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 22
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 115
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 54
- group Id
- BG003
- value
- 25
- group Id
- BG004
- value
- 249
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 16
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 64
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 298
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle